Cerecor Inc. Acquires Rights to NR2B Receptor Antagonist From Merck & Co., Inc. (MRK)
4/19/2013 9:03:55 AM
More...
|
Cerecor Inc. Acquires Rights to Merck & Co., Inc. (MRK) COMT Inhibitors
3/20/2013 7:33:17 AM
More...
|
Cerecor Inc. Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
12/6/2012 10:07:38 AM
More...
|
Cerecor Inc. Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
12/5/2012 9:34:58 AM
More...
|
Cerecor Inc. Announces Key Management Additions
10/18/2012 10:12:05 AM
More...
|
Dr. Magnus Persson Joins Cerecor Inc.'s Board of Directors
8/27/2012 10:35:50 AM
More...
|
Cerecor Inc. Announces Initiation of CLIN01-002-A
5/22/2012 10:04:44 AM
More...
|
Cerecor Inc. Announces Initiation of CLIN01-002-A
5/21/2012 8:05:44 AM
More...
|
Cerecor Inc. Announces Clearance of IND for FP01
4/11/2012 9:42:26 AM
More...
|
Cerecor Inc. Raises $22 Million Series A Financing
4/5/2012 6:25:27 AM
More...
|